|
|
Volumn 11, Issue 5, 2009, Pages 289-291
|
|
Commentary on the management of elevated blood pressure in pregnancy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA METHYLDOPAMINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIURETIC AGENT;
HYDRALAZINE;
BLOOD PRESSURE REGULATION;
DIASTOLIC BLOOD PRESSURE;
DRUG EFFICACY;
EXPERIENCE;
FEMALE;
FETUS MORTALITY;
HUMAN;
MATERNAL HYPERTENSION;
NOTE;
PATIENT SAFETY;
PRACTICE GUIDELINE;
PREECLAMPSIA;
PRIORITY JOURNAL;
RISK FACTOR;
SYSTOLIC BLOOD PRESSURE;
TOXEMIA;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
ADRENERGIC BETA-ANTAGONISTS;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
DIURETICS;
FEMALE;
HUMANS;
HYPERTENSION;
PREGNANCY;
PREGNANCY COMPLICATIONS, CARDIOVASCULAR;
|
|
EID: 66649122838
PISSN: 15246175
EISSN: 17517176
Source Type: Journal
DOI: 10.1111/j.1751-7176.2009.00127.x Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
